Share this page!

Peregrine Trader Profile picture
Twitter logo
19 Feb, 18 tweets, 4 min read
$QDEL on #PeregrineWatchlist after

18 Feb 21 AMC Earnings
Profit: $10.95 per share
+10.60% eBEAT
+0.20% rBEAT
Earnings Growth: +1,064.90% yoy
Revenue Growth: +431.70% yoy
2) 9975 Summers Ridge Road, Suite 200
San Diego, California
quidel.com
Sector: Health Care
Industry: Medical Supplies
Employees: 1,250
3) DESCRIPTION
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions.
4) The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers.
5) The company was founded in 1979 and is headquartered in San Diego, CA.
6) Summary as of 18 Feb 21
OPEN217.21
PREVIOUS CLOSE217.79
DAY RANGE208.19 - 218.40
52-WEEK RANGE72.99 - 306.72
ALL-TIME HIGH306.72
AVG. VOLUME (50-DAY)796,090
EPS (TTM)8.52
NEXT EARNINGS DATE2/18/2021 (AMC)
LAST EARNINGS DATE10/29/2020

OPTIONSYes
7) Fundamentals
P/E RATIO25.57
PEG RATIO0.07
PRICE TO BOOK10.78
PRICE TO CASH FLOW40.25
PRICE TO FREE CASH FLOW49.56
TOTAL SALES (TTM)1.005 B
REVENUE PER SHARE (TTM)23.04
SHARES OUTSTANDING42.04 M
SHARE FLOAT (%)37.11 M (88.23%)
% HELD BY INSTITUTIONS84.16
8) Technicals
+/- EMA(20)224.60 (-6.46%)
+/- SMA(50)210.60 (-0.24%)
+/- SMA(200)213.97 (-1.81%)
5-DAY PERF.-8.43%
1-MONTH PERF.+2.74%
3-MONTH PERF.+12.18%
6-MONTH PERF.-15.56%
YTD PERF.+16.95%
1-YEAR PERF.+163.09%
RSI(14)42.50
ATR(14)13.91
ADX(14)16.36
BETA (5Y)0.72
9) Short float: 7.09%
Short Ratio: 3.19
Recent 22 Jan 21 Upgrade by Raymond James:
Mkt Perform → Outperform$250
10) 10 Dec 21: "MedTech Dive’s editors and journalists selected Mr. Bryant as the medical technology industry’s Executive of the Year in part because his pre-COVID strategy of developing rapid immunoassay technologies . . . " finance.yahoo.com/news/quidel-co…
11) " . . . and building out point-of-care antigen testing for infectious diseases and conditions such as flu, RSV and strep positioned the company for success when the pandemic hit."
12) "MedTech Dive credited Mr. Bryant for redirecting Quidel to focus on the COVID-19 virus and dramatically increasing production of its diagnostic tests."
13) 14 Jan 21 finance.yahoo.com/news/3-reasons…
14) 19 Jan 21 Quidel is currently extended beyond a proper buy zone after clearing the 45.65 entry in a consolidation. It's currently peaking just above its 50-day moving average, a key technical benchmark
investors.com/news/quidel-ea…
15) My note: See my $QDEL chart again and notice it is resting on top 50 day moving average (pink dashed line) again:
16) 3 Feb 21

* Carlsbad, CA facility aims to reach a run rate of 600 million QuickVue® tests per year by end of 2021

* Future plans call for production of numerous popular QuickVue® diagnostic tests to serve the emerging at-home testing market

finance.yahoo.com/news/quidel-op…
17) 10 Feb 21 $QGEN $QDEL "Late on Monday, Bloomberg News reported that U.S.diagnostics firm Quidel Corp is looking to make atakeover offer for Qiagen . . . " finance.yahoo.com/news/1-qiagen-…
18) "a move that would follow ThermoFisher's bid from August 2020 that was rejected byshareholders as being underpriced." fool.com/earnings/call-…

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Peregrine Trader

Peregrine Trader Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @peregreine

Peregrine Trader Profile picture
19 Feb
1) #PeregrineUpgrades Fri, 19 Feb 21

$CDE ROTH Capital Neutral → Buy $10

$CG Credit Suisse Neutral → Outperform $42

$CLX Atlantic Equities Neutral → Overweight $233

$CNA Keefe Bruyette Mkt Perform → Outperform $52
2) #PeregrineUpgrades Fri, 19 Feb 21

$DXC BofA Securities Underperform → Neutral $27

$EVBG JP Morgan Neutral → Overweight $200

$FND Piper Sandler Neutral → Overweight $124

$HUBG UBS Neutral → Buy $67

$KBH Goldman Sell → Buy $51
3) #PeregrineUpgrades Fri, 19 Feb 21

$NMRK Piper Sandler Neutral → Overweight $12

$NTAP Longbow Neutral → Buy no PT

$NXGN Cantor Fitzgerald Neutral → Overweight $23

$SABR Deutsche Bank Hold → Buy $17

$UAA Oppenheimer Perform → Outperform $30
Read 4 tweets
Peregrine Trader Profile picture
19 Feb
1) $OPK announced earnings Thu, 18 Feb 21, AMC

Profit: +.05 CENTS
+25.00% eBEAT
+13.40% rBEAT
Earnings Growth: +183.30% yoy
Revenue Growth: +120.40% yoy
2) 4400 Biscayne Boulevard
Miami, Florida
opko.com
Sector: Health Care
Industry: Biotechnology
Employees: 6,096

Note: I live in the FL Keys and have never heard of this firm with over 6,096 employees?
3) DESCRIPTION
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference,as well as . . .
Read 25 tweets
Peregrine Trader Profile picture
19 Feb
1) $JMP just announced earnings AMC, Thu, 18 Feb 21

Before getting started, note this is very thinly traded, and yet yesterday, before earnings announced post-market, it traded 32 x its normal avg volume. So, today, I think we're going to see some madness in this name.
2) In a normal setting, yesterday's candlestick, called a "hanging man" would suggest the next day would be down. However, as always, an Earnings report can change everything on a dime. So, today, I'll follow to see how this all pans out and see if volume goes 100x. My bet? UP.
3) That said, let's "do it"

600 Montgomery Street, Suite 1100
San Francisco, California
jmpg.com
Sector: Financial
Industry: Investment Services
Employees: 209
Read 15 tweets
Peregrine Trader Profile picture
19 Feb
1) $PTON has turned bearish. A few days ago I was agnostic; now, were I trading this, I would have gone short this name two days ago. Extended trendline (thin line) shows busted horizontal and trendline support & trading under 50 day moving average.
2) Now that's just the chart look. The insider sales for $PTON since just last December (and especially in the past 10 days) tell you a story, and it is not bullish. Every time an insider vests options, they turn around and sell their shares. I don't see bullish buys here:
3) Be aware of product delays (chip shortages are real), and Buy Now Pay Later - although that is off-loaded to the firm Affirm (IIRC). Then, insider sales, and competition. $NLS and $LULU are not asleep during this exercise from home quarantine.
Read 7 tweets
Peregrine Trader Profile picture
18 Feb
1) $LGND on #PeregineWatchlist . . . already nibbling.

Last Earnings 3 Feb 21 BMO

Profit: $1.42 per share
+43.43% eBEAT
+29.00% rBEAT
Earnings Growth: +178.22% yoy
Revenue Growth: +159.20% yoy
2) 3911 Sorrento Valley Boulevard, Suite 110
San Diego, California
ligand.com
Sector: Health Care
Industry: Biotechnology
Employees: 115
3) DESCRIPTION
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines.
Read 33 tweets
Peregrine Trader Profile picture
18 Feb
1) Bulls vs. Bears Thread: A very bullish look: "The fact these extreme breadth readings keep pouring in as the rally progresses suggests we continue to be in a healthy market that is being driven by broadening participation." allstarcharts.com/february-confe…
2) "Most importantly, this is strong evidence that we are most likely at the beginning of a new bull market, not the end of an old one."
3) From the same link: "Speaking of this whole global growth and reflationary thesis we see playing out, here’s another development to add to the above list… New record highs for Emerging Markets $EEM." (Chart from All-Star Charts piece linked above.) Image
Read 17 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

Like this author's thread?

Get emails when @peregreine has new unrolls!

Check out other threads from @peregreine!

Read all threads by @peregreine